trending Market Intelligence /marketintelligence/en/news-insights/trending/u39xbrqq78acoun872z3ia2 content esgSubNav
In This List

Dova Pharmaceuticals plans common stock offering

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Dova Pharmaceuticals plans common stock offering

Dova Pharmaceuticals Inc. plans to sell 2.5 million of its common shares in an underwritten public offering.

The company also plans grant the underwriters an option to buy up to an additional 375,000 common shares.

J.P. Morgan Securities LLC, Jefferies LLC and Evercore Group LLC are serving as joint book-running managers for the offering.